A Phase I Trial Evaluating mFOLFOX6 and Avastin With Nexavar as First-Line Treatment for Metastatic Colorectal Cancer.

Trial Profile

A Phase I Trial Evaluating mFOLFOX6 and Avastin With Nexavar as First-Line Treatment for Metastatic Colorectal Cancer.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 31 Oct 2011

At a glance

  • Drugs Bevacizumab; Fluorouracil; Folinic acid; Oxaliplatin; Sorafenib
  • Indications Colorectal cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 18 Aug 2011 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
    • 18 Aug 2011 Planned end date changed from Dec 2010 to Mar 2011 as reported by ClinicalTrials.gov.
    • 20 Jul 2011 Actual end date (Mar 2011) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top